Skip to main content
. 2017 Aug 25;125(8):087018. doi: 10.1289/EHP1021

Table 3.

Adjusted mean [95% confidence interval (CI)] proportion of cycles resulting in implantation, live birth, and clinical pregnancy by quartile of urinary organophosphate flame retardant metabolite concentrations among 211 women undergoing 297 in vitro fertilization (IVF) cycles.

Condition ΣPFR BDCIPP DPHP ip-PPP
Implantation        
 Q1 0.71 (0.59, 0.81) 0.72 (0.59, 0.81) 0.69 (0.56, 0.79) 0.74 (0.62, 0.83)
 Q2 0.62 (0.49, 0.73) 0.58 (0.46, 0.70) 0.64 (0.52, 0.75) 0.50 (0.37, 0.62)
 Q3 0.57 (0.45, 0.69) 0.53 (0.41, 0.65) 0.56 (0.44, 0.68) 0.61 (0.48, 0.72)
 Q4 0.49 (0.37, 0.62)* 0.56 (0.43, 0.67) 0.50 (0.38, 0.62)* 0.54 (0.41, 0.66)*
 p-trend 0.02 0.06 0.02 0.05
Pregnancy        
 Q1 0.63 (0.50, 0.74) 0.61 (0.49, 0.73) 0.61 (0.49, 0.72) 0.63 (0.51, 0.74)
 Q2 0.54 (0.42, 0.66) 0.50 (0.38, 0.62) 0.55 (0.42, 0.66) 0.40 (0.29, 0.53)
 Q3 0.50 (0.38, 0.62) 0.47 (0.35, 0.59) 0.48 (0.36, 0.60) 0.51 (0.39, 0.63)
 Q4 0.37 (0.26, 0.50)* 0.45 (0.33, 0.57) 0.39 (0.28, 0.52)* 0.48 (0.36, 0.61)
 p-trend 0.004 0.06 0.01 0.19
Live birth        
 Q1 0.48 (0.35, 0.61) 0.49 (0.36, 0.61) 0.47 (0.34, 0.59) 0.53 (0.40, 0.65)
 Q2 0.42 (0.30, 0.55) 0.36 (0.24, 0.48) 0.42 (0.30, 0.55) 0.35 (0.24, 0.47)
 Q3 0.38 (0.27, 0.51) 0.36 (0.25, 0.49) 0.37 (0.26, 0.50) 0.35 (0.24, 0.48)
 Q4 0.30 (0.20, 0.43)* 0.36 (0.25, 0.49) 0.31 (0.21, 0.44) 0.35 (0.24, 0.48)
 p-trend 0.05 0.20 0.07 0.05

Note: Adjusted models control for maternal age (continuous), body mass index (continuous), race/ethnicity (black/Asian/other, white/Caucasian), year of IVF treatment cycle (continuous), and primary Society for Assisted Reproductive Technology (SART) infertility diagnosis at study entry (female, male, unknown). Adjusted means are presented for the mean maternal age (35.2), body mass index (23.9), race/ethnicity (white), year of IVF treatment cycle (2010), and primary SART infertility diagnosis at study entry (female=1 male=0, unexplained=0). BDCIPP, bis(1,3-dichloro-2-propyl) phosphate; DPHP, diphenyl phosphate; ip-PPP, isopropylphenyl phenyl phosphate; PFR, organophosphate flame retardant.

*

Significantly different from Q1 at the p=0.05 level.